The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab)

FHS
April 18, 2024
12:54 pm

The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab), are pleased to announce they have entered into a collaboration to deliver USP-ID, through Mestrelab’s Mnova platform.

Remote curriculum delivery during the pandemic creates optimal learning environment for medical students with disabilities

Medical students who reported a disability to their school increased by more than 25% during the COVID-19 pandemic, a study shows.

August 18, 2023

Hiring in the Indian pharma industry drop by 23% in Q2 2023

Notably, Management Occupations jobs accounted for a 28% share of the Indian’s pharma industry new job postings in Q2 2023, down by 21% over the

July 28, 2023

Brain activity changes predict recovery from early PTSD symptoms

After a traumatic experience, most people recover without incident, but some people – between 2% and 10%- develop posttraumatic stress disorder (PTSD), a mental health

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.